[1] BIGGS P M. The Leeuwenhoek Lecture,1997.
Marek's disease herpesvirus:oncogenesis and prevention[J].Philos Trans R Soc Lond B Biol Sci, 1997, 352(1364):1951-1962.
[2] CALNEK B W. Marek's disease-a model for herpesvirus oncology[J].Crit Rev Microbiol, 1986, 12(4):293-320.
[3] CALNEK B W. Pathogenesis of Marek's disease virus infection[J].Curr Top Microbiol Immunol, 2001, 255:25-55.
[4] BHATTACHARYA S D, GARRISON J, GUO H T, et al. Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell lines[J].Surgery, 2010, 148(2):291-297.
[5] XU H T, YAO Y X,SMITH L P,et al.MicroRNA-26a-mediated regulation of interleukin-2 expression in transformed avian lymphocyte lines[J].Cancer Cell Int, 2010, 10:15.
[6] LI X, LIAN L, ZHANG D X, et al.gga-miR-26a targets NEK6 and suppresses Marek's disease lymphoma cell proliferation[J]. Poult Sci, 2014, 93(5):1097-1105.
[7] FAVREAU A J, SATHYANARAYANA P. miR-590-5p,miR-219-5p,miR-15b and miR-628-5p are commonly regulated by IL-3,GM-CSF and G-CSF in acute myeloid leukemia[J].Leuk Res, 2012, 36(3):334-341.
[8] BARTEL D P.MicroRNAs:genomics,biogenesis,mechanism,and function[J]. Cell, 2004, 116(2):281-297.
[9] BRENNECKE J, STARK A, RUSSELL R B, et al. Principles of microRNA-target recognition[J]. PLoS Biol, 2005, 3(3):e85.
[10] YAO Y X, ZHAO Y G,SMITH L P, et al. Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines[J]. J Gen Virol, 2009, 90(Pt 7):1551-1559.
[11] ZHAO Y G,YAO Y X,XU H T,et al.A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus[J]. J Virol, 2009, 83(1):489-492.
[12] CHI J Q, TENG M,YU Z H, et al. Marek's disease virus-encoded analog of microRNA-155 activates the oncogene c-Myc by targeting LTBP1 and suppressing the TGF-β signaling pathway[J].Virology, 2015, 476:72-84.
[13] LI Z J,ZHANG Y P,LI Y,et al.Distinct expression pattern of miRNAs in Marek's disease virus infected-chicken splenic tumors and non-tumorous spleen tissues[J]. Res Vet Sci, 2014, 97(1):156-161.
[14] BURNSIDE J,OUYANG M,ANDERSON A, et al. Deep sequencing of chicken microRNAs[J].BMC Genomics, 2008, 9:185.
[15] LIAN L,LI X,ZHAO C F, et al. Chicken gga-miR-181a targets MYBL1 and shows an inhibitory effect on proliferation of Marek's disease virus-transformed lymphoid cell line[J]. Poult Sci, 2015, 94(11):2616-2621.
[16] LIAN L, QU L J, CHEN Y M, et al. A systematic analysis of miRNA transcriptome in Marek's disease virus-induced lymphoma reveals novel and differentially expressed miRNAs[J].PLoS One, 2012, 7(11):e51003.
[17] LI X,LIAN L,ZHANG D X, et al.gga-miR-26a targets NEK6 and suppresses Marek's disease lymphoma cell proliferation[J]. Poult Sci, 2014, 93(5):1097-1105.
[18] LIAN L,LI X,ZHAO C F,et al.Chicken gga-miR-181a targets MYBL1 and shows an inhibitory effect on proliferation of Marek's disease virus-transformed lymphoid cell line[J]. Poult Sci, 2015, 94(11):2616-2621.
[19] HAN B, LIAN L, LI X, et al.Chicken gga-miR-130a targets HOXA3 and MDFIC and inhibits Marek's disease lymphoma cell proliferation and migration[J].Mol Biol Rep, 2016, 43(7):667-676.
[20] ZHAO C F, LI X, HAN B, et al.Gga-miR-219b targeting BCL11B suppresses proliferation,migration and invasion of Marek's disease tumor cell MSB1[J]. Sci Rep, 2017, 7:4247.
[21] TIAN F, LUO J, ZHANG H M, et al. MiRNA expression signatures induced by Marek's disease virus infection in chickens[J].Genomics, 2012, 99(3):152-159.
[22] AKIYAMA Y, KATO S. Two cell lines from lymphomas of Marek's disease[J].Biken J, 1974, 17(3):105-116.
[23] NAZERIAN K. An updated list of avian cell lines and transplantable tumours[J].Avian Pathol, 1987, 16(3):527-544.
[24] TAN X G, QIN W Y, ZHANG L, et al. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis[J].Clin Cancer Res, 2011, 17(21):6802-6811.
[25] MILES G D, SEILER M, RODRIGUEZ L, et al. Identifying microRNA/mRNA dysregulations in ovarian cancer[J].BMC Res Notes, 2012, 5:164.
[26] SAND M,SKRYGAN M,GEORGAS D, et al. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma[J].J Dermatol Sci, 2012, 68(3):119-126.
[27] SAND M,SKRYGAN M, SAND D, et al. Expression of microRNAs in basal cell carcinoma[J].Br J Dermatol, 2012, 167(4):847-855.
[28] ZOU M X,HUANG W,WANG X B, et al. Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma[J]. Int J Clin Exp Pathol, 2014, 7(8):4877-4885.
[29] TIAN F, LUO J, ZHANG H M, et al. MiRNA expression signatures induced by Marek's disease virus infection in chickens[J].Genomics, 2012, 99(3):152-159.
[30] LIAN L, ZHANG D X, WANG Q, et al. The inhibitory effects of gga-miR-199-3p,gga-miR-140-3p,and gga-miR-221-5p in Marek's disease tumorigenesis[J].Poult Sci, 2015, 94(9):2131-2135.
[31] BURNSIDE J, OUYANG M, ANDERSON A, et al. Deep sequencing of chicken microRNAs[J]. BMC Genomics, 2008, 9:185.
[32] SONG B, WANG Y, XI Y, et al. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells[J].Oncogene, 2009, 28(46):4065-4074.
[33] GU R,SUN Y F, WU M F, et al. Biological roles of microRNA-140 in tumor growth, migration, and metastasis of osteosarcoma in vivo and in vitro[J].Tumour Biol, 2016, 37(1):353-360.
[34] KONG X M, ZHANG G H, HUO Y K, et al. MicroRNA-140-3p inhibits proliferation, migration and invasion of lung cancer cells by targeting ATP6AP2[J]. Int J Clin Exp Pathol, 2015, 8(10):12845-12852.
[35] DONG W, YAO C P, TENG X P, et al. MiR-140-3p suppressed cell growth and invasion by downregulating the expression of ATP8A1 in non-small cell lung cancer[J].Tumour Biol, 2016, 37(3):2973-2985.
[36] STETLER-STEVENSON W G, AZNAVOORIAN S,LIOTTA L A. Tumor cell interactions with the extracellular matrix during invasion and metastasis[J].Annu Rev Cell Biol, 1993, 9(1):541-573.
[37] SUN J, HEMLER M E. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions[J]. Cancer Res, 2001, 61(5):2276-2281.
[38] LUO Y,LIANG F B,ZHANG Z Y.PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways[J]. Biochemistry, 2009, 48(8):1838-1846.
[39] TABOURET E,BOUDOURESQUE F,FARINA P,et al.MMP2 and MMP9 as candidate biomarkers to monitor bevacizumab therapy in high-grade glioma[J].Neuro Oncol, 2015, 17(8):1174-1176. |